InspireMD, Inc. NSPR
Set alert
0.45 USD 0.00 -0.31%
At close · Oct 30
0.44 -0.01 -2.00%
After hours · Oct 30, 4:00 PM ET
0.44 Day range 0.4729
0.43 52-week range 2.40
- YTD
- -74.72%
- 1 year
- -79.45%
- Open
- 0.44
- Prev close
- 0.4514
- Mkt cap
- 20.92M
- Vol
- 478.66K
- Avg vol
- 138.15K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.44
- High
- 0.4729
- Forward P/E
- -4.15
- Beta
- 0.00
- Short ratio
- 2.26
- Inst. own
- 40.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.69
- 200-d avg
- 2.57
- 1y target
- 4.75
2Y chart
Events in this range
- Nov 12, 2024Earnings: -0.16; estimate -0.2; surprise 20%
- Dec 11, 2024Rating: Lake Street · — → Buy
Signals (84)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| RSI: Oversold | Jun 23, 2026 | 4 months ago |
| RSI: Oversold | Jun 18, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| RSI: Oversold | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 2, 2026 | 5 months ago |
| RSI: Oversold | May 26, 2026 | 5 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| RSI: Oversold | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| RSI: Oversold | Apr 23, 2026 | 6 months ago |
| RSI: Oversold | Apr 7, 2026 | 6 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 17, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 27, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 26, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| SMA: Bullish | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 25, 2025 | 1 year ago |
| SMA: Bearish | Jun 24, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| SMA: Bearish | Jun 5, 2025 | 1 year ago |
| SMA: Bullish | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 14, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 15, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 11, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 4, 2025 | 1 year ago |
| RSI: Overbought | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| SMA: Bearish | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| RSI: Overbought | Nov 26, 2024 | 1 year ago |
Key statistics
- Market cap
- 76.95M
- Enterprise value
- 37.44M
- Trailing P/E
- 0.00
- Forward P/E
- -4.15
- PEG ratio
- 0.00
- Price / sales
- 11.28
- Price / book
- 1.83
- EPS (TTM)
- -0.71
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 6.82M
- Revenue growth
- 16.30%
- Free cash flow
- 0
- Total cash
- 40.40M
- Total debt
- 682.00K
- Return on equity
- -66.75%
- Shares outstanding
- 26.08M
- Short % of float
- 0.90%
- 50-day average
- 2.69
- 200-day average
- 2.57
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 4.75 +955.6% upside
Now 0.45
- Target (low)
- 4.50
- Target (mean)
- 4.75
- Target (high)
- 5.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.195.
Financials — quick view
NSPR Revenue — quarterly 1.77M
NSPR Net income — quarterly -14.32M
NSPR EPS — quarterly -0.17
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.20 | -0.16 | +0.04 | +20.00% |
| Aug 6, 2024 | Jun 1, 2024 | -0.19 | -0.22 | -0.03 | -15.79% |
| May 14, 2024 | Mar 1, 2024 | -0.15 | -0.21 | -0.06 | -40.00% |
| Mar 6, 2024 | Dec 1, 2023 | -0.20 | -0.16 | +0.04 | +20.00% |
| Nov 6, 2023 | Sep 1, 2023 | -0.17 | -0.15 | +0.02 | +11.76% |
| Aug 8, 2023 | Jun 1, 2023 | -0.17 | -0.24 | -0.07 | -41.18% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | Lake Street | init | — | Buy |
| Nov 2, 2023 | Piper Sandler | main | Overweight | Overweight |
| Jun 12, 2023 | Piper Sandler | init | — | Overweight |
| May 17, 2023 | National Alliance Securities | main | — | Buy |
| Mar 31, 2023 | Alliance Global Partners | main | — | Buy |
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Israel
- Website
- inspiremd.com
News
- InspireMD to Announce Third Quarter 2026 Financial Results
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
- Full Transcript: InspireMD Q2 2026 Earnings Call
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
- InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
- InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on NSPR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARNOLD KATHRYN | Director | Stock Award(Grant) | Jan 22, 2024 | 215,040 |
| BERMAN MICHAEL | Director | Conversion of Exercise of derivative security | Jun 23, 2024 | 0 |
| GLEASON SHANE THOMAS | Officer | Stock Award(Grant) | Jan 22, 2024 | 514,365 |
| KESTER THOMAS J | Director | Conversion of Exercise of derivative security | May 27, 2024 | 326,652 |
| ROUBIN GARY S | Director | Conversion of Exercise of derivative security | May 27, 2024 | 501,788 |
| SHORE CRAIG | Chief Financial Officer | Stock Award(Grant) | Jan 22, 2024 | 879,844 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.64% | 2,514,046 | 7.42M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 8.47% | 2,209,593 | 6.52M | Sep 29, 2024 |
| Orbimed Advisors LLC. | 8.18% | 2,133,405 | 6.29M | Sep 29, 2024 |
| Marshall Wace LLP | 7.13% | 1,860,405 | 5.49M | Sep 29, 2024 |
| Soleus Capital Management, L.P. | 5.28% | 1,378,128 | 4.07M | Sep 29, 2024 |
| Velan Capital Investment Management LP | 3.47% | 904,029 | 2.67M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.07% | 18,244 | 53.82K | Oct 30, 2024 |